Recent studies employing whole-genome and targeted sequencing have identified frequent mutations in the ARID1A and PIK3CA genes in ovarian clear cell carcinomas, along with modest alterations in PPP2R1A and KRAS. Similar PTEN, CTNNB1, and KRAS mutations have been discovered in endometrioid cancer. This evidence concerns the gene KRAS and ovarian clear cell cancer.